I agree... it's the way to really get the medical community directly on board and should be easy for them to understand how effective Leronlimab could/would be...

https://investorshangout.com/post/view?id=5721619

Despite counting 31 companies in the ' Forbes ' listing that have some kind of 'Treatment' (and I know one other NYSE company here in CT not even on the list), I believe most of them don't come close to CytoDyn in terms how far ahead we are with the drug, testing, FDA or efficacy and safety...

https://www.forbes.com/sites/giacomotognini/2...a94f845899